AI Terminal
CHILL BRANDS GROUP PLC
Declaration of Voting Results & Voting Rights Announcements • Mar 31, 2021
4943_rns_2021-03-31_7e155ff1-1dd9-4d29-a481-9f309486b355.html
Declaration of Voting Results & Voting Rights Announcements
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 9687T
Zoetic International PLC
31 March 2021
31 March 2021
Zoetic International plc
('Zoetic', the 'Company' or the 'Group')
Total Voting Rights
Zoetic International plc (LSE: ZOE), the international CBD group, announces that the issued share capital of the Company at the date of this announcement comprises 196,570,034 ordinary shares of 1 pence each with one voting right per share ('Ordinary Shares'). The Company does not hold any Ordinary Shares in treasury. The total number of Ordinary Shares and voting rights in the Company is therefore 196,570,034.
This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Publication on website
A copy of this announcement is also available on the Group's website at www.zoeticinternational.com
Media enquiries:
| Zoetic International plc | c/o Buchanan |
| Trevor Taylor, Co-CEO Antonio Russo, Co-CEO |
|
| Allenby Capital Limited (Financial Adviser and Broker) | +44 (0) 20 3328 5656 |
| Nick Harriss (Corporate Finance) | |
| Nick Naylor (Corporate Finance) | |
| Guy McDougall (Equity Sales) | |
| Buchanan | |
| Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz | Tel: +44 (0) 20 7466 5000 |
| [email protected] | www.buchanan.uk.com |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TVREAEDEDANFEFA